Researchers have found positive results in the creation of a genetically engineered compound that attacks the protein in the gene HER-2/neu, which is present in a high number of breast cancer cases. The compound enhances the killing ability of chemotherapy by weakening the strength of the tumor-causing protein in HER-2/neu. Several women who were treated with the compound found that their tumors disappeared, shrank, and in one case actually disappeared. Over a hundred breast cancer centers around the world are testing the new compound. For more information call 1-800-821-8590.